Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBATMH. pylori SIA
Open Access
- 1 August 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 14 (8), 1929-1933
- https://doi.org/10.1093/ndt/14.8.1929
Abstract
Background. There are few data concerning the epidemiology of H. pylori in patients on chronic haemodialysis (HD) treatment. These surveys concerned small populations and were made with ELISA technique. However, ELISA-based assays do not differentiate between strains of H. pylori that are associated with ulcers. Recent literature reports that formation of ulcers correlates strongly with the expression of cytotoxin-associated protein (CagA) and vacuolating cytotoxin (VacA) of H. pylori. Methods. A novel serological test (RIBATMH. pylori strip immunoblot assay (SIA)) has been recently introduced, it uses the H.pylori lysate (Lys) along with two additional purified recombinant antigens derived from CagA and VacA of H. pylori. Aim. To study the epidemiology of H. pylori using RIBATMH. pylori SIA among chronic HD patients and blood donors as a control group. In addition, the activity of H. pylori was analysed by immunoblot technique in a group of patients with documented ulcers and normal renal function. Results. The prevalence of antibody towards H. pylori among HD patients, blood donors, and patients with documented ulcers was 56% (127/228), 53% (84/158), and 100% (21/21) respectively; the difference was significant (P=0.0001). The frequency of anti-H. pylori-positive individuals was significantly higher in patients with documented ulcers than HD patients and blood donors, 21/21 (100%) vs 211/386 (55%), P=0.0001. The frequency of antibody to H. pylori in the HD population was significantly associated with race (P=0.005); no relationship between anti-H. pylori antibody and numerous demographic, biochemical, and clinical features of patients was seen. The frequency of antibodies against virulent strains of H. pylori in HD patients and blood donors with H.pylori was 60% (76/127) and 61% (51/84) respectively; it was 86% (18/21) among individuals with documented ulcers. No significant difference among these three groups occurred. Conclusions. The frequency of antibody towards H. pylori by RIBATMH. pylori SIA was high both in HD patients and blood donors; patients with documented ulcers and normal renal function had significantly higher frequency of anti-H. pylori antibody. The anti-H. pylori antibody rate among HD patients was strongly associated with race. The prevalence of antibody against virulent strains of H.pylori did not change among HD patients and control groups. Studies in large cohorts of HD patients with documented peptic ulcer disease are in progress.Keywords
This publication has 18 references indexed in Scilit:
- Helicobacter pylori infection in haemodialysis patients and renal transplant recipientsNephrology Dialysis Transplantation, 1997
- Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serologyNephrology Dialysis Transplantation, 1996
- Significantly lower prevalence ofHelicobacter pylori in uremic patients than in patients with normal renal functionThe Esophagus, 1995
- Prevalence of Helicobacter pylori in Patients with End-Stage Renal Failure and Renal Transplant RecipientsNephron, 1991
- Prevalence of Helicobacter pylori Antibodies in Patients on Chronic Intermittent HaemodialysisNephron, 1991
- Antral Helicobacter pylori in patients with chronic renal failure.Journal of Clinical Pathology, 1990
- Campylobacter pylori in Uremic Dialyzed PatientsNephron, 1989
- Prevalence of peptic ulcer in patients undergoing maintenance hemodialysisDigestive Diseases and Sciences, 1988
- The Clinical Significance of Campylobacter pyloriAnnals of Internal Medicine, 1988
- GASTRIC FUNCTION IN CHRONIC RENAL FAILURE EFFECTS OF MAINTENANCE HÆMODIALYSISThe Lancet, 1975